These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date, and reported results||2005-000840-10||Open Label Phase II Multicenter Study for the Evaluation of Pharmacokinetics of VENBIG (Human Immunoglobulin anti-Hepatitis B for Intravenous Use) and IMMUNOHBS (Human Immunoglobulin anti Hepatitis B ...||bad-data|
|Completed, but no date, and reported results||2005-001136-76||Double blind Randomized Controlled trial of prolonged treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)with high dose intravenous immunoglobulins (IVIg) or intravenous meti...||bad-data|
|Completed, but no date, and reported results||2005-006186-14||Open Label Phase II Evaluation of Pharmacokinetics, Efficacy, and Safety of Kedrion Human Plasma-derived Antihaemophilic Double Virus inactivated and Nanofiltered Factor IX Administered to Previously ...||bad-data|
|Completed, but no date, and reported results||2007-005583-27||A multi-center, randomized, prospective, controlled open-label Phase II/III study to assess the safety and sealing efficacy of Kedrion Fibrin Sealant in patients eligible for anatomical pulmonary rese...||bad-data|
|Completed, but no date, and reported results||2009-011603-23||Evaluation of Haemostatic Efficacy, Tolerability and Safety of Kedrion Fibrin Sealant in patients undergoing major or minor Liver Surgery. Multicenter, Controlled, Open Label Randomised Phase II/III...||bad-data|
|Completed, but no date, and reported results Terminated||2010-020167-20||Pharmacokinetics, efficacy, tolerability and safety evaluation of the therapy with subcutaneous immunoglobulin in the treatment of hypo or agammaglobulinaemic patients. Open label phase II/III study||bad-data|
|Ongoing||2010-021473-36||Efficacy and Safety evaluation of Kedrion Human Hepatitis B Immunoglobulin for intramuscular use in the prevention of hepatitis B in the newborns of Hepatitis B Virus carrier-mothers: multi-centre, ...||not-yet-due|
|Completed, but no date, and reported results||2010-023991-15||Efficay and Safety Evaluation of Kedrion Fibrin Sealant, in middle ear microsurgery. Monocenter, controlled, single blind, randomised, two parallel arms, phase II/III study||bad-data|
|Ongoing||2012-001340-21||A Historically-Controlled Phase II/III study to Evaluate Efficacy and Safety of Kedrion Human Plasminogen Eye Drop Preparation in Patients Diagnosed with Ligneous Conjunctivitis||not-yet-due|
|No trial status on register||2012-002328-34||Efficacy and safety evaluation of Kedrion Fibrin Sealant as an adjuvant for the control of hemostasis in pediatric patients undergoing abdominal or orthopedic surgery. Multicenter, randomized, control...||bad-data|
|Ongoing||2012-002342-21||Valutazione dell’Efficacia e della Sicurezza della Colla di Fibrina Kedrion come coadiuvante per il controllo dell’emostasi in pazienti pediatrici sottoposti ad interventi di cardiochirurgia a cuore a...||not-yet-due|
|Reported results||2013-000961-36||Tolerability and safety evaluation of the administration of Ig VENA at high infusion rates. Open label phase III study.||2015-03-31||due-trials|